Entity

Time filter

Source Type

Cambridge, MA, United States

Founded in 1982, the Whitehead Institute for Biomedical Research is a non-profit research and teaching institution located in Cambridge, Massachusetts, USA.The Whitehead Institute was founded as a fiscally independent entity from Massachusetts Institute of Technology , and its 17 members hold faculty appointments in the MIT Department of Biology. The Institute is named for businessman and philanthropist Edwin C. "Jack" Whitehead, who selected David Baltimore as the Whitehead Institute's Founding Director. Baltimore chose Gerald Fink, Rudolf Jaenisch, Harvey Lodish, and Robert Weinberg as the Whitehead Institute's Founding Members.The institute is one of the world's leading centers for genomic research. Its Center for Genome Research was active in the Human Genome Project, and reportedly contributed one-third of the human genome sequence announced in June 2000.In June 2003, Eli and Edythe L. Broad pledged $100 million to build the Broad Institute, a joint venture of Whitehead, MIT, Harvard and local teaching hospitals. The new venture's mission is to expand tools for genomic medicine and apply them for the treatment of disease.Less than a decade after its founding, the Whitehead Institute was named the top research institution in the world in molecular biology and genetics, and over a recent 10-year period, papers published by Whitehead scientists had more impact in molecular biology and genetics than those from any of the 15 leading research universities and life science institutes in the United States. Four times since 2009, the Whitehead Institute has been ranked first as the Best Place to Work for Postdocs in USA by The Scientist magazine.Whitehead has a world-renowned faculty that includes the recipients of the 1997, 2010, and 2011 National Medal of Science ; nine members of the National Academy of science ; five Members of the Institute of Medicine ; and seven Fellows of the American Academy of Arts and science . Wikipedia.


Shin C.,Whitehead Institute For Biomedical Research
Molecular cell | Year: 2010

Most metazoan microRNA (miRNA) target sites have perfect pairing to the seed region, located near the miRNA 5' end. Although pairing to the 3' region sometimes supplements seed matches or compensates for mismatches, pairing to the central region has been known to function only at rare sites that impart Argonaute-catalyzed mRNA cleavage. Here, we present "centered sites," a class of miRNA target sites that lack both perfect seed pairing and 3'-compensatory pairing and instead have 11-12 contiguous Watson-Crick pairs to the center of the miRNA. Although centered sites can impart mRNA cleavage in vitro (in elevated Mg(2+)), in cells they repress protein output without consequential Argonaute-catalyzed cleavage. Our study also identified extensively paired sites that are cleavage substrates in cultured cells and human brain. This expanded repertoire of cleavage targets and the identification of the centered site type help explain why central regions of many miRNAs are evolutionarily conserved. Copyright (c) 2010 Elsevier Inc. All rights reserved. Source


Gehring M.,Whitehead Institute For Biomedical Research
Annual Review of Genetics | Year: 2013

Imprinted gene expression-the biased expression of alleles dependent on their parent of origin-is an important type of epigenetic gene regulation in flowering plants and mammals. In plants, genes are imprinted primarily in the endosperm, the triploid placenta-like tissue that surrounds and nourishes the embryo during its development. Differential allelic expression is correlated with active DNA demethylation by DNA glycosylases and repressive targeting by the Polycomb group proteins. Imprinted gene expression is one consequence of a large-scale remodeling to the epigenome, primarily directed at transposable elements, that occurs in gametes and seeds. This remodeling could be important for maintaining the epigenome in the embryo as well as for establishing gene imprinting. © 2013 by Annual Reviews. All rights reserved. Source


Patent
Whitehead Institute For Biomedical Research | Date: 2015-07-17

Methods of depleting one or more target nucleic acid sequences using the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR associated (Cas) proteins (CRISPR/Cas) system are disclosed. Kits and methods of producing a library comprising select mRNA sequences using the CRISPR/Cas system are also disclosed.


Patent
Sangamo BioSciences and Whitehead Institute For Biomedical Research | Date: 2015-10-29

Disclosed herein are methods and compositions for correction and/or mutation of genes associated with Parkinsons Disease as well as clones and animals derived therefrom.


Patent
Whitehead Institute For Biomedical Research | Date: 2015-03-24

Disclosed are genes that, when overexpressed in cells expressing alpha-synuclein, either suppress or enhance alpha-synuclein mediated cellular toxicity. Compounds that modulate expression of these genes or activity of the encoded proteins can be used to inhibit alpha-synuclein mediated toxicity and used to treat or prevent synucleinopathies such as Parkinsons disease. Also disclosed are methods of identifying inhibitors of alpha-synuclein mediated toxicity.

Discover hidden collaborations